Gland Pharma Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Gland Pharma Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014097
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Gland Pharma Ltd (Gland Pharma) is a healthcare products provider that develops and manufactures active pharmaceutical ingredients. The company’s products include injectables, pre filled syringes, vials, ampoules, infusions, ophthalmic solutions, lyophilized vials, dry powders, lyophilized products, glycosominoglycans molecules, high-potent drugs, and long-acting suspensions. It offers tartrate and timolol ophthalmic solutions and suspensions, ophthalmic emulsion, heparin, antibodies, hydrochloride ophthalmic solutions, anesthetic products, critical cardiology products, critical care products, anti infective and gastrointestinal products. Gland Pharma’s services include contract development and manufacturing, clinical batch manufacturing, and others. The company also provides synthesis of complex drug molecules such as low molecular weight heparins and anti-cancer drugs. It has its facilities in Hyderabad and Visakhapatnam, India. Gland Pharma is headquartered in Hyderabad, Telangana, India.

Gland Pharma Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Gland Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Gland Pharma Ltd, Medical Devices Deals, 2011 to YTD 2017 10
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
KKR Receives Government Approval To Acquire 35% Stake In Gland Pharma For USD200 Million 12
Partnerships 13
Breckenridge Pharma Enters into Marketing Agreement with Gland Pharma 13
Dr. Reddy’s Labs Enters into Co-Marketing Agreement with Gland Pharma 14
Litha Pharma Partners with Gland Pharma 15
Licensing Agreements 16
Athenex to Enter into Licensing Agreement with Gland Pharma 16
Athenex to Enter into Licensing Agreement with Gland Pharma 17
Acquisition 18
Shanghai Fosun Pharma Acquires 74% Stake in Gland Pharma for USD1.1 Billion 18
Gland Pharma Ltd – Key Competitors 20
Gland Pharma Ltd – Key Employees 21
Gland Pharma Ltd – Locations And Subsidiaries 22
Head Office 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Gland Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Gland Pharma Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Gland Pharma Ltd, Medical Devices Deals, 2011 to YTD 2017 10
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
KKR Receives Government Approval To Acquire 35% Stake In Gland Pharma For USD200 Million 12
Breckenridge Pharma Enters into Marketing Agreement with Gland Pharma 13
Dr. Reddy’s Labs Enters into Co-Marketing Agreement with Gland Pharma 14
Litha Pharma Partners with Gland Pharma 15
Athenex to Enter into Licensing Agreement with Gland Pharma 16
Athenex to Enter into Licensing Agreement with Gland Pharma 17
Shanghai Fosun Pharma Acquires 74% Stake in Gland Pharma for USD1.1 Billion 18
Gland Pharma Ltd, Key Competitors 20
Gland Pharma Ltd, Key Employees 21

★海外企業調査レポート[Gland Pharma Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Foundation Medicine Inc (FMI):企業の財務・戦略的SWOT分析
    Summary Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd, is a molecular information products provider. The company provides molecular information and cancer research programs. It offers clinical products such as FoundationOne for solid tumors and FoundationOne …
  • Karolinska University Hospital:製薬・医療:M&Aディール及び事業提携情報
    Summary Karolinska University Hospital (KUH), a subsidiary of Karolinska Institutet is a healthcare service provider that offers patient care, research and education programs. The hospital offers cross border medical care by referring patients or by tele medicine and health care at a distance. It of …
  • Sonivate Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Sonivate Medical Inc (Sonivate Medical) is a medical device company that develops and manufactures diagnostic imaging technologies. The company offers dual-plane ultrasound probe, a finger-mounted ultrasound probe that leverages innate human hand eye coordination, which with any ultrasound s …
  • CenterPoint Energy Inc (CNP):電力:M&Aディール及び事業提携情報
    Summary CenterPoint Energy Inc (CenterPoint) is an energy utility company that carries out electric transmission and distribution, and natural gas distribution. It is also involved in natural gas sales and service, pipeline services and other field services. The company sells regulated intrastate na …
  • Sabre Corporation (SABR):企業の財務・戦略的SWOT分析
    Sabre Corporation (SABR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Filtration Group Corp:企業の戦略的SWOT分析
    Filtration Group Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Chiesi USA Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Chiesi USA Inc (Chiesi USA), a subsidiary of Chiesi Farmaceutici S.p.A, is a specialty pharmaceutical company. It researches, develops, produces and commercializes therapies in cardiovascular, respiratory, neonatology, rare disease and special care therapeutics. The company's product portfol …
  • Takeda Pharmaceutical Company Limited:企業のM&A・事業提携・投資動向
    Takeda Pharmaceutical Company Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Takeda Pharmaceutical Company Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • Humana Inc (HUM)-製薬・医療分野:企業M&A・提携分析
    Summary Humana Inc (Humana) is a health and well-being company that offers health insurance and Medicare plans, insurance products, and health and wellness services to healthcare providers, employers, individuals, administrators, government, and the public sector. The company’s Medicare products and …
  • AS Kevelt-製薬・医療分野:企業M&A・提携分析
    Summary AS Kevelt (Kevelt), a subsidiary of Pharmsynthez is a healthcare company that develops, manufactures and markets drug products. The company offers products which include concentrate solutions for infusion, endocervical gel, eye drops and other solutions. It also offers sub-contracting and di …
  • Atlas Elektronik GmbH:企業の戦略・SWOT・財務情報
    Atlas Elektronik GmbH - Strategy, SWOT and Corporate Finance Report Summary Atlas Elektronik GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Hannover Ruck SE:企業の戦略・SWOT・財務分析
    Hannover Ruck SE - Strategy, SWOT and Corporate Finance Report Summary Hannover Ruck SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196)-製薬・医療分野:企業M&A・提携分析
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …
  • Kumagai Gumi Co., Ltd.:企業の戦略・SWOT・財務分析
    Kumagai Gumi Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kumagai Gumi Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bharat Sanchar Nigam Ltd:企業の戦略的SWOT分析
    Bharat Sanchar Nigam Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Diehl Defence Holding GmbH:企業の戦略的SWOT分析
    Diehl Defence Holding GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • SNC-Lavalin Group Inc.:企業の戦略・SWOT・財務分析
    SNC-Lavalin Group Inc. - Strategy, SWOT and Corporate Finance Report Summary SNC-Lavalin Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Spectrum Brands Holdings, Inc.:企業のM&A・事業提携・投資動向
    Spectrum Brands Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Spectrum Brands Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Altern Energy Ltd (ALTN):企業の財務・戦略的SWOT分析
    Altern Energy Ltd (ALTN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • AnaMar AB-製薬・医療分野:企業M&A・提携分析
    Summary AnaMar AB (AnaMar), a subsidiary of Koncentra Holding AB, discovers, develops and commercializes therapeutic strategies to treat debilitating inflammation, fibrosis and pain. The company develops drug candidates from several chemical classes that concentrates on the receptors and shows poten …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆